![John D. Weinberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John D. Weinberg
No open positions remaining
Profile
John D.
Weinberg worked as the Head of Oncology Business Unit at Enzon Pharmaceuticals, Inc. from 2003 to 2005.
He was the SVP of Commercial Operations & Investor Relations at Veloxis Pharmaceuticals A from 2010 to 2012.
He also worked as the Head of Business Franchise at Novartis Pharmaceuticals Corp.
and as the Chief Medical Officer at 4D Pharma Plc.
In 2020, he became the Chief Medical Officer at Maat Pharma SA. Weinberg holds an MBA from INSEAD and a doctorate from the University of the Witwatersrand.
Former positions of John D. Weinberg
| Companies | Position | End |
|---|---|---|
| MAAT PHARMA | Chief Tech/Sci/R&D Officer | 2022-05-31 |
| VELOXIS PHARMACEUTICALS A/S | Chief Operating Officer | 2016-02-28 |
Enzon Pharmaceuticals, Inc.
 Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Corporate Officer/Principal | 2004-12-31 |
| 4D PHARMA PLC | Chief Tech/Sci/R&D Officer | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | - |
Training of John D. Weinberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
31
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Pharma Plc
 4D Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which engages in the development of live bio therapeutics | Health Technology |
Maat Pharma SA
 Maat Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops and commercializes patient-microbiome symbiosis to improve survival outcomes in oncology | Health Technology |
- Stock Market
- Insiders
- John D. Weinberg
